← FDA Drug Approvals (Drugs@FDA)
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2025-01-28
Drug application
- FDA Application #
ANDA214611- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- Generic name
- TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- Active ingredients
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- MACLEODS PHARMS LTD
- Manufacturer
- Macleods Pharmaceuticals Limited
- First approval
- 2025-01-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown